SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16
Article in Acta Pharmacologica Sinica (October 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Acta Pharmacologica Sinica (October 2022)
Article in International Journal of Biological Sciences (January 2022)